Tardive dyskinesia can affect many areas of your life, including your social life and self-confidence. Learning how to manage these effects can help improve your overall well-being and daily ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

CEO Richard Francis reflects on Teva’s return to growth during his tenure, and what’s next for the drugmaker in its quest to ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) Q4 2024 Earnings Conference Call February 6, 2025 4:30 PM ET Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive Officer Matt ...

Additionally, it has been used for depression, attention deficit hyperactivity disorder (ADHD), Alzheimer's disease, autism, and tardive dyskinesia ... dark under-eye circles, and neck firmness ...

A short educational activity on tardive dyskinesia significantly improved clinicians’ confidence in managing and choosing therapies. Separate studies recently published in the European Journal of ...

Valbenazine and vitamin E are the most effective treatments for tardive dyskinesia, with valbenazine showing the strongest effect size in recent studies. Transcranial direct current stimulation shows ...

Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose. HealthDay News — Antipsychotics at doses >75 mg/day are associated with ...

Tardive dyskinesia is primarily associated with the use of certain medications, particularly antipsychotic medications used to treat conditions like schizophrenia, bipolar disorder, and other ...

There are some studies of Botox for off-label uses, such as tardive dyskinesia (involuntary movements of the face and body). (Off-label use means to use a drug for a purpose other than what it’s ...